Tissue Regenix Group PLC (LON:TRX), the regenerative medical devices company, has said it intends to appoint Brian Phillips and Trevor Phillips (no relation) as independent non-executive directors of the company.
It noted that Brian Phillips is an entrepreneurial investment professional with over 25 years’ experience. He is the current principal of Ethos partners which he co-founded in 2018 to assist individuals in establishing a portfolio of assets under private equity investments. Prior to this, he was chief investment officer at Greenhill Capital Partners Europe where he was responsible for setting up their UK business (2006-2010) and managing director of LGV Capital (2000-2006).
The group pointed out that Trevor Phillips is the current chairman of the Board at NEPeSMO and has extensive experience in the UK and US in corporate development, M&A and operations in the pharmaceutical and life science industries including previously held positions as executive chairman of hVIVO (2017-2020), chief operating officer for Vectura Group PLC (2011-2017) and former CEO and COO of Critical Therapeutics, Inc. (2002-2008).
READ: Tissue Regenix hails significant milestone as it ships new product line to first customer
Both will be appointed to the board of Tissue Regenix following the completion of the necessary regulatory due diligence in accordance with the AIM Rules, the company said, with Brian Phillips to chair the Audit Committee and Trevor Phillips to chair the Renumeration Committee.
Alongside these appointments, the group noted that, after many years of service, Alan Miller and Randeep Grewal have notified the board of their resignation as non-executive directors with immediate effect.
In a statement, Jonathan Glenn, interim chair of Tissue Regenix, commented: “As we focus on leveraging our operational capabilities and driving the commercialisation of our product pipelines, I am pleased to welcome Brian and Trevor to the Board who both bring a wealth of experience that will be crucial in shaping the future strategy and success of the Group. I would like to extend my thanks to Alan and Randeep who have been highly committed Board members and have supported the Group for many years.”
